Xenetic Biosciences Inc. (XBIO)
NASDAQ: XBIO
· Real-Time Price · USD
3.24
-0.05 (-1.51%)
At close: Oct 03, 2025, 3:58 PM
3.21
-0.93%
After-hours: Oct 03, 2025, 07:39 PM EDT
-1.51% (1D)
| Bid | 2.95 |
| Market Cap | 5M |
| Revenue (ttm) | 2.45M |
| Net Income (ttm) | -3.08M |
| EPS (ttm) | -1.97 |
| PE Ratio (ttm) | -1.64 |
| Forward PE | -0.99 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 3.38 |
| Volume | 30,443 |
| Avg. Volume (20D) | 26,822 |
| Open | 3.26 |
| Previous Close | 3.29 |
| Day's Range | 2.86 - 3.26 |
| 52-Week Range | 2.20 - 5.27 |
| Beta | 2.44 |
| Ex-Dividend Date | n/a |
About XBIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol XBIO
Website n/a
Xenetic Biosciences Inc. is scheduled to release its earnings on
Nov 11, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago · accessnewswire.com
Xenetic Biosciences, Inc. Reports Second Quarter 2025 Financial ResultsExpanded strategic partnership with The Scripps Research Institute to advance proof-of-concept studies and further develop its program combining systemic DNase I with CAR T-cell therapies Ended the qu...
